Gulf News: $411 billion vision-loss cost raises stakes for UAE specialty care

A 29 June 2026 Gulf News opinion by Dr. Zain Kenderian puts the UAE specialty-care case on one number: $411 billion in annual productivity losses from untreated vision loss.

Kenderian, chief executive of Bascom Palmer Eye Institute Abu Dhabi, argues that CEOs, CFOs and medical directors should treat outbound patient travel as a capital-allocation problem. The immediate takeaway is measurable: Gulf News cites a $247 billion global outbound medical tourism market in 2024, with a forecast above $755 billion by 2034.

The patient leakage problem

The Gulf News article cites the Lancet Global Health Commission for the $411 billion annual productivity loss tied to preventable and untreated vision loss. It also cites the GCC medical tourism market at $9.6 billion in 2025, a regional data point that makes the UAE question more concrete for hospital boards.

"patients still board flights for care they should receive at home" — Dr. Zain Kenderian, Bascom Palmer Eye Institute Abu Dhabi

For UAE operators, that sentence points to a revenue leak. A patient who leaves Abu Dhabi for a retinal procedure, cardiac intervention or oncology opinion takes the procedure bill, diagnostics, pharmacy spend and follow-up activity out of the domestic system. Kenderian adds that airfare, lost productivity and weeks away from work raise the economic cost beyond the hospital invoice.

Why the UAE model matters

The UAE has already moved toward the model Kenderian describes. He names Cleveland Clinic Abu Dhabi, Mayo Clinic advisory partnerships and Bascom Palmer Eye Institute as examples of globally branded academic institutions placed inside a publicly supported system. The same article says healthcare spending is under 5% of GDP today and is projected to reach 5.1% by 2029.

The policy backdrop is explicit. The national We the UAE 2031 vision includes a healthcare quality target tied to global rankings by 2031. For private operators, the investable gap is specialty care that combines licensed clinical talent, insurer acceptance, referral credibility and regulator-ready reporting.

• $411 billion: annual global productivity loss from untreated and preventable vision loss, cited by Gulf News from the Lancet Global Health Commission.
• $247 billion: global outbound medical tourism market in 2024, as cited by Gulf News.
• $755 billion: projected global outbound medical tourism market by 2034.
• $9.6 billion: GCC medical tourism market value in 2025, according to the Gulf News article.
• 5.1%: projected UAE healthcare spending share of GDP by 2029, as cited by Kenderian.

What operators should watch

Hospital owners and investors should test whether specialty expansion can convert outbound demand into domestic volume by 2027. The answer depends on Department of Health Abu Dhabi, Dubai Health Authority and Ministry of Health and Prevention licensing, plus insurer coding, referral pathways and consultant availability.

CFOs should test a specialty-care business case against four numbers: outbound patient capture, average reimbursement per episode, diagnostics retained after consultation and follow-up retention after surgery. A centre that wins surgery but loses imaging, pharmacy or rehabilitation has a weaker margin profile than the headline procedure volume suggests.

CIOs have a separate due-diligence question in 2026: whether external academic partners can work inside local electronic medical record systems, claims workflows and regulator reporting rules. Kenderian cites Malaffi, Abu Dhabi's health information exchange, as linking more than 2,700 facilities, and the Emirati Genome Programme as holding genomic data from more than 500,000 citizens.

The boardroom takeaway is specific. Ophthalmology, oncology and complex cardiology are the specialties to watch because Kenderian names them as gaps that can be closed through subspecialty centres. The number to remember is $411 billion, but the UAE decision is local: which patients still leave, and what clinical proof would make them stay?